Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (62) 62
medicin och hälsovetenskap (58) 58
life sciences & biomedicine (57) 57
humans (55) 55
oncology (35) 35
immunotherapy (26) 26
female (25) 25
immunology (21) 21
middle aged (21) 21
aged (18) 18
adult (17) 17
male (17) 17
medicine (16) 16
cancer (14) 14
care and treatment (13) 13
prognosis (13) 13
analysis (12) 12
biological and medical sciences (12) 12
medical sciences (12) 12
melanoma (12) 12
melanoma - immunology (12) 12
tumors (12) 12
animals (11) 11
medicine, research & experimental (11) 11
research & experimental medicine (11) 11
antineoplastic agents (10) 10
melanoma - pathology (10) 10
pharmacology. drug treatments (10) 10
t cells (10) 10
aged, 80 and over (9) 9
metastasis (9) 9
neoplasm staging (9) 9
treatment outcome (9) 9
biochemistry, genetics and molecular biology (8) 8
biomarkers (8) 8
health aspects (8) 8
research (8) 8
cancer research (7) 7
neoplasms - immunology (7) 7
patients (7) 7
reproducibility of results (7) 7
signal transduction (7) 7
antigens (6) 6
chemotherapy (6) 6
clinical trials (6) 6
colorectal cancer (6) 6
medicine & public health (6) 6
meeting report (6) 6
melanoma - therapy (6) 6
mice (6) 6
neoplasms - therapy (6) 6
proteins (6) 6
research article (6) 6
survival (6) 6
tumor microenvironment (6) 6
antibodies, monoclonal - therapeutic use (5) 5
biomarkers, tumor - metabolism (5) 5
cancer och onkologi (5) 5
cancer therapies (5) 5
cell line (5) 5
clinical trials as topic (5) 5
cytotoxicity (5) 5
dermatology (5) 5
immune response (5) 5
immunohistochemistry (5) 5
ipilimumab (5) 5
italy (5) 5
lymphocytes (5) 5
medical and health sciences (5) 5
medical research (5) 5
usage (5) 5
biology (4) 4
biomarkers, tumor (4) 4
cell biology (4) 4
cohort studies (4) 4
cytokines (4) 4
development and progression (4) 4
flow cytometry (4) 4
gene expression (4) 4
histocompatibility antigens (4) 4
hla histocompatibility antigens (4) 4
medical prognosis (4) 4
melanoma - drug therapy (4) 4
multidisciplinary sciences (4) 4
multivariate analysis (4) 4
neoplasms - pathology (4) 4
ovarian neoplasms - genetics (4) 4
patient outcomes (4) 4
peptides (4) 4
proportional hazards models (4) 4
radiation therapy (4) 4
radiotherapy (4) 4
review (4) 4
science (4) 4
science & technology - other topics (4) 4
surgery (4) 4
survival analysis (4) 4
tumors of the skin and soft tissue. premalignant lesions (4) 4
amino acid sequence (3) 3
antigen presentation (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
by Festino, Lucia and Botti, Gerardo and Lorigan, Paul and Masucci, Giuseppe V and Hipp, Jason D and Horak, Christine E and Melero, Ignacio and Ascierto, Paolo A
Drugs (New York, N.Y.), ISSN 0012-6667, 06/2016, Volume 76, Issue 9, pp. 925 - 945
Pharmacology & Pharmacy | Toxicology | Life Sciences & Biomedicine | Science & Technology | Neoplasms - metabolism | B7-H1 Antigen - metabolism | Humans | Biomarkers, Tumor - metabolism | Tumor Microenvironment | Antibodies, Monoclonal - therapeutic use | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Molecular Targeted Therapy | Neoplasms - drug therapy | Patient Selection
Journal Article
Details down arrow
2. Full Text Gender differences in prognostic value of immune-related biomarkers in colon cancer patients randomized to surgery or surgery and adjuvant chemotherapy treatment
by Villabona, Lisa and Masucci, Giuseppe V and Ragnhammar, Peter
Journal of clinical oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 3603 - 3603
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Immature Immunosuppressive CD14(+)HLA-DR-/low Cells in Melanoma Patients Are Stat3(hi) and Overexpress CD80, CD83, and DC-Sign
by Poschke, Isabel and Mougiakakos, Dimitrios and Hansson, Johan and Masucci, Giuseppe V and Kiessling, Rolf
Cancer research (Chicago, Ill.), ISSN 0008-5472, 06/2010, Volume 70, Issue 11, pp. 4335 - 4345
Life Sciences & Biomedicine | Oncology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Sex Differences in Overall Survival and the Effect of Radiotherapy in Merkel Cell Carcinoma-A Retrospective Analysis of A Swedish Cohort
by Andtback, Hannah Bjorn and Bjornhagen-Safwenberg, Viveca and Shi, Hao and Lui, Weng-Onn and Masucci, Giuseppe and Villabona, Lisa
Cancers, ISSN 2072-6694, 01/2021, Volume 13, Issue 2, p. 265
Life Sciences & Biomedicine | Oncology | Science & Technology | Immune response | Pathogenesis | Sex differences | Gender differences | Radiation therapy | Patients | Clinical outcomes | Skin cancer | Survival analysis | Medical prognosis | Surgery | Older people | Tumors | radiotherapy | merkel cell polyoma virus | merkel cell carcinoma | sex | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Patient-reported outcomes in KEYNOTE-006, a randomised study of pembrolizumab versus ipilimumab in patients with advanced melanoma
by Petrella, Teresa M and Robert, Caroline and Richtig, Erika and Miller, Wilson H and Masucci, Giuseppe V and Walpole, Euan and Lebbe, Celeste and Steven, Neil and Middleton, Mark R and Hille, Darcy and Zhou, Wei and Ibrahim, Nageatte and Cebon, Jonathan
European journal of cancer (1990), ISSN 0959-8049, 11/2017, Volume 86, pp. 115 - 124
Health-related quality of life | Pembrolizumab | Patient-reported outcomes | Advanced melanoma | KEYNOTE-006 | EORTC QLQ-C30 | Life Sciences & Biomedicine | Oncology | Science & Technology | Skin Neoplasms - pathology | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Skin Neoplasms - drug therapy | Humans | Middle Aged | Male | Treatment Outcome | Ipilimumab - adverse effects | Melanoma - pathology | Antineoplastic Agents, Immunological - adverse effects | Time Factors | Antineoplastic Agents, Immunological - therapeutic use | Ipilimumab - therapeutic use | Melanoma - drug therapy | Quality of Life | Female | Health Status | Patient Reported Outcome Measures | Medicine, Experimental | Medical research | Care and treatment | Patient outcomes | Analysis | Melanoma | Data analysis | Clinical trials | Data processing | Patients | Clinical outcomes | Public health | Quality of life | Cancer | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Immature immunosuppressive CD14+HLA-DR-/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign
by Poschke, Isabel and Mougiakakos, Dimitrios and Hansson, Johan and Masucci, Giuseppe V and Kiessling, Rolf
Cancer research (Chicago, Ill.), ISSN 0008-5472, 06/2010, Volume 70, Issue 11, pp. 4335 - 4345
Tumors of the skin and soft tissue. Premalignant lesions | Dermatology | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Tumors | Melanoma - blood | Antigens, CD - immunology | Cell Communication - immunology | Immunoglobulins - immunology | Antigens, CD - biosynthesis | Humans | Membrane Glycoproteins - biosynthesis | Middle Aged | Lectins, C-Type - immunology | Oxidative Stress - immunology | Male | Lectins, C-Type - biosynthesis | Cell Adhesion Molecules - immunology | Interleukin-4 Receptor alpha Subunit - biosynthesis | Myeloid Cells - immunology | Calgranulin B - immunology | Aged, 80 and over | Adult | Female | Receptors, Cell Surface - biosynthesis | B7-1 Antigen - biosynthesis | Membrane Glycoproteins - immunology | Immunoglobulins - biosynthesis | Calgranulin B - biosynthesis | B7-1 Antigen - immunology | Cell Adhesion Molecules - biosynthesis | Lymphocyte Activation | Lipopolysaccharide Receptors - immunology | Interleukin-4 Receptor alpha Subunit - immunology | Receptors, Cell Surface - immunology | STAT3 Transcription Factor - biosynthesis | Melanoma - immunology | Interferon-gamma - immunology | T-Lymphocytes - immunology | Aged | HLA-DR Antigens - immunology | STAT3 Transcription Factor - immunology | Interferon-gamma - biosynthesis | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Effectiveness of PD1-inhibitors in advanced Merkel cell carcinoma: Real life data in a Swedish cohort
by Bjorn-Andtback, Hannah and Masucci, Giuseppe V and Villabona, Lisa Elena Esther
Journal of clinical oncology, ISSN 0732-183X, 05/2020, Volume 38, Issue 15_suppl, pp. e22063 - e22063
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text HLA-dependent tumour development: A role for tumour associate macrophages?
by Marchesi, Maddalena and Andersson, Emilia and Villabona, Lisa and Seliger, Barbara and Lundqvist, Andreas and Kiessling, Rolf and Masucci, Giuseppe V
Journal of translational medicine, ISSN 1479-5876, 10/2013, Volume 11, Issue 1, pp. 247 - 247
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Macrophages - pathology | Signal Transduction | Neoplasms - immunology | Humans | HLA Antigens - immunology | Neoplasms - pathology | Macrophages - immunology | Receptors, Immunologic - metabolism | Killer cells | Histocompatibility antigens | T cells | Macrophages | HLA histocompatibility antigens | Tumors | Index Medicus | Angiogenesis | Review | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text The need for a network to establish and validate predictive biomarkers in cancer immunotherapy
by Masucci, Giuseppe V and Cesano, Alessandra and Eggermont, Alexander and Fox, Bernard A and Wang, Ena and Marincola, Francesco M and Ciliberto, Gennaro and Dobbin, Kevin and Puzanov, Igor and Taube, Janis and Wargo, Jennifer and Butterfield, Lisa H and Villabona, Lisa and Thurin, Magdalena and Postow, Michael A and Sondel, Paul M and Demaria, Sandra and Agarwala, Sanjiv and Ascierto, Paolo A
Journal of translational medicine, ISSN 1479-5876, 11/2017, Volume 15, Issue 1, pp. 223 - 223
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Neoplasms - therapy | Reproducibility of Results | Internationality | Neoplasms - immunology | Humans | Immunotherapy | Biomarkers, Tumor - metabolism | Statistics as Topic | Medical research | Care and treatment | Clinical trials | Medicine, Experimental | Management | Methods | Cancer | Studies | Consortia | Collaboration | Lung cancer | Melanoma | Biomarkers | Cancer therapies | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Analysis of immune-related prognostic markers in colon cancer patients randomized to surgery or surgery and adjuvant cytostatic treatment
by Villabona, Lisa and Masucci, Giuseppe V and Ragnhammar, Peter
Journal of clinical oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e15102 - e15102
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma
by Poschke, Isabel and Lövgren, Tanja and Adamson, Lars and Nyström, Maria and Andersson, Emilia and Hansson, Johan and Tell, Roger and Masucci, Giuseppe V and Kiessling, Rolf
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 10/2014, Volume 63, Issue 10, pp. 1061 - 1071
Immunology | DC vaccine | Medicine & Public Health | Tumor-infiltrating lymphocytes | Melanoma | Oncology | Cancer Research | Combination (immuno)therapy | Adoptive T cell transfer | Life Sciences & Biomedicine | Science & Technology | Immunotherapy, Adoptive - methods | Dendritic Cells - immunology | Humans | Middle Aged | Lymphocytes, Tumor-Infiltrating - transplantation | Male | Melanoma - pathology | Young Adult | Vaccination - methods | Melanoma - immunology | Adolescent | Adult | Female | Aged | Melanoma - therapy | Neoplasm Staging | Dendritic Cells - transplantation | Lymphocytes, Tumor-Infiltrating - immunology | Complications and side effects | Chemotherapy | Dendritic cells | Vaccination | Clinical trials | T cells | Cancer | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Validation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validation
by Masucci, Giuseppe V and Cesano, Alessandra and Hawtin, Rachael and Janetzki, Sylvia and Zhang, Jenny and Kirsch, Ilan and Dobbin, Kevin K and Alvarez, John and Robbins, Paul B and Selvan, Senthamil R and Streicher, Howard Z and Butterfield, Lisa H and Thurin, Magdalena
Journal for immunotherapy of cancer, ISSN 2051-1426, 11/2016, Volume 4, Issue 1, pp. 76 - 76
Assay | Validation | Biomarker | Immunotherapy | Standardization | Cancer | Immunotherapy - methods | Reproducibility of Results | Biological Assay - standards | Prognosis | Humans | Neoplasms - mortality | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Treatment Outcome | Biological Assay - methods | Clinical Trials as Topic | Neoplasms - diagnosis | Molecular Targeted Therapy | Biomarkers, Tumor | Antineoplastic Agents, Immunological - pharmacology | Neoplasms - therapy | B7-H1 Antigen - antagonists & inhibitors | Antineoplastic Agents, Immunological - therapeutic use | CTLA-4 Antigen - antagonists & inhibitors | Care and treatment | Analysis | Research | Biological markers | Health aspects | Antigens | Lymphocytes | Biomarkers | T cell receptors | Patients | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Stereotactic Ablative Radio Therapy (SABR) followed by immunotherapy a challenge for individualized treatment of metastatic solid tumours
by Masucci, Giuseppe V and Wersäll, Peter and Kiessling, Rolf and Lundqvist, Andreas and Lewensohn, Rolf
Journal of translational medicine, ISSN 1479-5876, 05/2012, Volume 10, Issue 1, pp. 104 - 104
Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Neoplasm Metastasis | Neoplasms - therapy | Humans | Immunotherapy | Radiotherapy - methods | Neoplasms - radiotherapy | Combined Modality Therapy | Neoplasms - pathology | Care and treatment | Chemotherapy | Ionizing radiation | Metastasis | Cancer | Lymphocytes | Biomarkers | T cell receptors | Radiation therapy | Radios | Drug dosages | Cancer therapies | Manuscripts | Tumors | Skin cancer | Apoptosis | Index Medicus | Translation | Cytokines | Vaccination | Radiation | Radiotherapy | Kidney | Metastases | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights